7.00% p.a. Kick-In GOAL

Underlying: Lonza / Novartis / Roche / Vifor Pharma AG SSPA/EUSIPA Product Type: Barrier Reverse Convertibles (1230) Valor: 38955892 / ISIN: CH0389558922

Last update 16.11.2018
  • Bid

    97.10 %
    Volume: 100'000

  • Ask

    98.10 %
    Volume: 100'000

Strike100.00%
CurrencyCHF
IssuerUBS AG, London Branch
Settlementphysical
Fixing date13.12.2017
Expiry15.06.2020
Trading placeSIX SP Exchange
Barrier59.00%
Barrier touchedNo
Sideways return12.87% / 7.91% p.a.
Accrued interest2)2.90%
Underlying price1)
Lonza
Novartis
Roche
Vifor Pharma AG

305.10 CHF
87.66 CHF
250.30 CHF
130.80 CHF
Display
  • Product chart

Barrier monitor

NameRoche
Price1)250.30 CHF
Distance to barrier
43.03%
Barrier absolute142.603 CHF
Worst Performer
NameLonza
Price1)305.10 CHF
Distance to barrier
48.58%
Barrier absolute156.881 CHF
 
NameVifor Pharma AG
Price1)130.80 CHF
Distance to barrier
44.29%
Barrier absolute72.865 CHF
 
NameNovartis
Price1)87.66 CHF
Distance to barrier
43.56%
Barrier absolute49.4715 CHF
 
1) Prices are Real time. 2) Indicative